Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

Edwards, M. ORCID: 0000-0001-5190-7073, Gallagher, A., Nair, P., Drew, S., Vyas, A., Sharma, R., Marsden, P.A. and Evans, D.J.W., 2018. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews (1): CD012929. ISSN 1469-493X

[img]
Preview
Text
12889_Edwards.pdf - Published version

Download (212kB) | Preview

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.

Item Type: Journal article
Publication Title: Cochrane Database of Systematic Reviews
Creators: Edwards, M., Gallagher, A., Nair, P., Drew, S., Vyas, A., Sharma, R., Marsden, P.A. and Evans, D.J.W.
Publisher: Wiley
Date: 22 January 2018
Number: 1
ISSN: 1469-493X
Identifiers:
NumberType
10.1002/14651858.CD012929DOI
Rights: Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Divisions: Schools > Nottingham Business School
Depositing User: Jonathan Gallacher
Date Added: 18 Dec 2018 16:06
Last Modified: 22 Jan 2019 03:00
URI: http://irep.ntu.ac.uk/id/eprint/35380

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year